Liz Weston: Are Medicare Advantage plans worth the risk? By LIZ WESTON of NerdWallet - Associated Press Shares
Trump signs executive order to lower Medicare drug prices By Dave Boyer - The Washington Times Shares
Fad or future? Telehealth expansion eyed beyond pandemic By RICARDO ALONSO-ZALDIVAR - Associated Press Shares
Trump issues nursing home, hospital coronavirus requirements By Ricardo Alonso-Zaldivar - Associated Press Shares
New COVID-19 mandates on health care facilities get pushback By RICARDO ALONSO-ZALDIVAR - Associated Press Shares
Trump wants broader role for telehealth services in Medicare By RICARDO ALONSO-ZALDIVAR - Associated Press Shares
With no new law to curb drug costs, Trump tries own changes By RICARDO ALONSO-ZALDIVAR - Associated Press Shares
With no new law to curb drug costs, Trump tries own changes By RICARDO ALONSO-ZALDIVAR - Associated Press Shares
Trump signs order to align drug prices with other nations By Tom Howell Jr. - The Washington Times Shares
Watchdog report faults Medicare agency’s contract management By RICHARD LARDNER - Associated Press Shares
COVID-19 data on Medicare’s nursing home site is incomplete By RICARDO ALONSO-ZALDIVAR - Associated Press Shares
Medicare data: Blacks likelier to be hospitalized for COVID By RICARDO ALONSO-ZALDIVAR - Associated Press Shares
Court strikes down Trump rule that drugmakers disclose price By RICARDO ALONSO-ZALDIVAR - Associated Press Shares
AP FACT CHECK: Trump falsely blames Obama for pricey drugs By RICARDO ALONSO-ZALDIVAR - Associated Press Shares
White House announces plan to lower insulin co-pays for certain seniors By Dave Boyer - The Washington Times Shares
Most Medicare enrollees could get insulin for $35 a month By RICARDO ALONSO-ZALDIVAR - Associated Press Shares